Skip to main content

Main menu

  • Home
  • Content
    • Current Issue
    • Past Issues
    • Accepted Articles
    • Email Alerts
    • RSS
    • Terms of Use
  • About PDA JPST
    • JPST Editors and Editorial Board
    • About/Vision/Mission
    • Paper of the Year
  • Author & Reviewer Resources
    • Author Resources / Submit
    • Reviewer Resources
  • JPST Access and Subscriptions
    • PDA Members
    • Institutional Subscriptions
    • Nonmember Access
  • Support
    • Join PDA
    • Contact
    • Feedback
    • Advertising
    • CiteTrack
  • .
    • Visit PDA
    • PDA Letter
    • Technical Reports
    • news uPDATe
    • Bookstore

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
PDA Journal of Pharmaceutical Science and Technology
  • .
    • Visit PDA
    • PDA Letter
    • Technical Reports
    • news uPDATe
    • Bookstore
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
PDA Journal of Pharmaceutical Science and Technology

Advanced Search

  • Home
  • Content
    • Current Issue
    • Past Issues
    • Accepted Articles
    • Email Alerts
    • RSS
    • Terms of Use
  • About PDA JPST
    • JPST Editors and Editorial Board
    • About/Vision/Mission
    • Paper of the Year
  • Author & Reviewer Resources
    • Author Resources / Submit
    • Reviewer Resources
  • JPST Access and Subscriptions
    • PDA Members
    • Institutional Subscriptions
    • Nonmember Access
  • Support
    • Join PDA
    • Contact
    • Feedback
    • Advertising
    • CiteTrack
  • Follow pda on Twitter
  • Visit PDA on LinkedIn
  • Visit pda on Facebook
Review ArticleReview

A Semiquantitative Risk Assessment Methodology Fit for Biopharmaceutical Life Cycle Stages

Ajay Babu Pazhayattil, Naheed Sayeed-Desta, Shu Chen and Marzena Ingram
PDA Journal of Pharmaceutical Science and Technology July 2020, 74 (4) 423-434; DOI: https://doi.org/10.5731/pdajpst.2019.010173
Ajay Babu Pazhayattil
1Pharmaceutical Management Consultant, 565 Doan's Ridge Road, Welland ON L3B 5N7, Canada;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: ajpazha@gmail.com
Naheed Sayeed-Desta
2Sanofi Pasteur, 1755 Steeles Avenue W, North York, ON M2R 3T4, Canada;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shu Chen
3Apotex Inc., 150 Signet Drive, Toronto ON M9L 1T9, Canada; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marzena Ingram
4Eurofins Alphora Research Inc., 2450 Bristol Circle, Oakville, ON L6H 6P6, Canada.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • References
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 74 no. 4 423-434
DOI 
https://doi.org/10.5731/pdajpst.2019.010173
PubMed 
32060222

Published By 
Parenteral Drug Association (PDA)
Print ISSN 
1079-7440
Online ISSN 
1948-2124
History 
  • Published online July 31, 2020.

Article Versions

  • previous version (February 14, 2020 - 07:26).
  • You are viewing the most recent version of this article.
Copyright & Usage 
© PDA, Inc. 2020

Author Information

  1. Ajay Babu Pazhayattil1,*,
  2. Naheed Sayeed-Desta2,
  3. Shu Chen3 and
  4. Marzena Ingram4
  1. 1Pharmaceutical Management Consultant, 565 Doan's Ridge Road, Welland ON L3B 5N7, Canada;
  2. 2Sanofi Pasteur, 1755 Steeles Avenue W, North York, ON M2R 3T4, Canada;
  3. 3Apotex Inc., 150 Signet Drive, Toronto ON M9L 1T9, Canada; and
  4. 4Eurofins Alphora Research Inc., 2450 Bristol Circle, Oakville, ON L6H 6P6, Canada.
  1. ↵*Corresponding Author: 565 Doan's Ridge Rd., Welland ON L3B 5N7, Canada; Telephone: 647-339-9637; E-mail: ajpazha{at}gmail.com
View Full Text

Cited By...

  • 7 Citations
  • Google Scholar

This article has been cited by the following articles in journals that are participating in Crossref Cited-by Linking.

  • Risk assessment on drug production safety based on Grey-Analytic Network Process
    Jiaojiao Ge, Benhong Peng, Guo Wei, Anxia Wan
    Kybernetes 2023 52 3
  • Technology Transfer
    Ajay Babu Pazhayattil, Sanjay Sharma, Joe Paul Philip, Michelle Gischewski-Silva, Marzena Ingram
    2023 10
  • A visual safety risk evaluation tool in early clinical phases
    Kathrin Wawra-Hehenberger, Vanessa Pencelli, January Anne Pardo, Lothar Tremmel, Quazi Ataher, Max Waschbusch
    Contemporary Clinical Trials 2025 154
  • Aspects and Implementation of Pharmaceutical Quality by Design from Conceptual Frameworks to Industrial Applications
    Shiwei Yang, Xingming Hu, Jinmiao Zhu, Bin Zheng, Wenjie Bi, Xiaohong Wang, Jialing Wu, Zimeng Mi, Yifei Wu
    Pharmaceutics 2025 17 5
  • Pharmaceutical Manufacturing Deviation and Failure Investigations
    Ajay Babu Pazhayattil, Sanjay Sharma
    2025 3
  • Product and service quality risks: A survey about evolution and application in different business domains to facilitate quality engineering
    Alexander Poth
    Journal of Software: Evolution and Process 2024 36 9
  • Technology Transfer
    Ajay Babu Pazhayattil, Sanjay Sharma, Joe Paul Philip, Michelle Gischewski-Silva, Marzena Ingram
    2023 10
PreviousNext
Back to top

In This Issue

PDA Journal of Pharmaceutical Science and Technology: 74 (4)
PDA Journal of Pharmaceutical Science and Technology
Vol. 74, Issue 4
July/August 2020
  • Table of Contents
  • Index by Author
  • Complete Issue (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on PDA Journal of Pharmaceutical Science and Technology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
A Semiquantitative Risk Assessment Methodology Fit for Biopharmaceutical Life Cycle Stages
(Your Name) has sent you a message from PDA Journal of Pharmaceutical Science and Technology
(Your Name) thought you would like to see the PDA Journal of Pharmaceutical Science and Technology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
7 + 7 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
A Semiquantitative Risk Assessment Methodology Fit for Biopharmaceutical Life Cycle Stages
Ajay Babu Pazhayattil, Naheed Sayeed-Desta, Shu Chen, Marzena Ingram
PDA Journal of Pharmaceutical Science and Technology Jul 2020, 74 (4) 423-434; DOI: 10.5731/pdajpst.2019.010173

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
A Semiquantitative Risk Assessment Methodology Fit for Biopharmaceutical Life Cycle Stages
Ajay Babu Pazhayattil, Naheed Sayeed-Desta, Shu Chen, Marzena Ingram
PDA Journal of Pharmaceutical Science and Technology Jul 2020, 74 (4) 423-434; DOI: 10.5731/pdajpst.2019.010173
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Scope Determination and Product/Process Review
    • CQA Identification
    • Material Attribute/Process Parameter Identification
    • Material Attributes/Process Parameters Classification and Risk Factor Assignment
    • Computing Risk Ratio and Constructing Risk Assessment Charts
    • Potential Applications
    • Conflict of Interest Declaration
    • References
  • Figures & Data
  • References
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • The Role of Microbiologists in Drug Product Development
  • A Risk Assessment and Risk-Based Approach Review of Pre-Use/Post-Sterilization Integrity Testing (PUPSIT)
  • Recommendations for Artificial Intelligence Application in Continued Process Verification: A Journey Toward the Challenges and Benefits of AI in the Biopharmaceutical Industry
Show more Review

Similar Articles

Keywords

  • Risk assessment
  • Quality by Design
  • Pharmaceutical quality systems
  • Validation

Readers

  • About
  • Table of Content Alerts/Other Alerts
  • Subscriptions
  • Terms of Use
  • Contact Editors

Author/Reviewer Information

  • Author Resources
  • Submit Manuscript
  • Reviewers
  • Contact Editors

Parenteral Drug Association, Inc.

  • About
  • Advertising/Sponsorships
  • Events
  • PDA Bookstore
  • Press Releases

© 2025 PDA Journal of Pharmaceutical Science and Technology Print ISSN: 1079-7440  Digital ISSN: 1948-2124

Powered by HighWire